Global Point of Care
The first FDA approved rapid point-of-care test that detects both HIV-1/2 antibodies and free HIV-1 p24 antigen. This antigen/antibody test (4th generation) has the ability to identify HIV earlier than antibody-only tests (2nd and 3rd generation).1 It enables health care providers to diagnose HIV infection earlier allowing individuals to seek medical care sooner.
Only available in the US.
CLIA-waived for fingerstick whole blood
It’s the first antigen/antibody rapid point-of-care test that detects both HIV-1/2 antibodies and free HIV-1 p24 antigen on a single test strip.
Built-in quality controls to let you know the test is working.
Test in three simple steps with clear results in just 20 minutes.
The first antigen/antibody test, with the ability to detect HIV earlier than antibody-only tests.1
Test using whole blood, serum or plasma samples.
Proved 99.9% overall clinical sensitivity for all sample types.
Click image for full size view.
By detecting HIV earlier, you are helping to prevent further transmission during this extremely infectious early stage.
Information Type | Product Detail |
Method | Lateral Flow |
Time to results | 20 minutes |
Results window | 20-30 minutes after starting test |
Test lines | HIV-1 p24 antigen |
Storage conditions | 2-30°C (36-86°F) |
Test shelf life | 24 months* |
External controls shelf life | 24 months** |
Sample type | Wholeblood/serum/plasma |
Operating temperature | 15-30°C (59 to 86°F) |
Sample Type | Overall Clinical | Overall Clinical |
Fingerstick Whole Blood | 99.9% | 99.8% |
Venous Whole Blood | 99.9% | 99.7% |
Serum | 99.9% | 99.6% |
Plasma | 99.9% | 99.7% |
Determine™ HIV-1/2 Ag/Ab | Code |
Determine™ HIV-1/2Ag/Ab Combo (25 Tests) | 7D2648 |
External Controls | 7D2628 |
Verification Panel | KZMC030 |
1. Masciotra, S, et al. Performance of the Alere Determine™ HIV-1/2 Ag/Ab Combo Rapid Test with specimens from HIV-1 seroconverters from the US and HIV-2 infected individuals from Ivory Coast. J Clin Virol 2013: Published online 05 August 2013. DOI: 10.1016/j.jcv.2013.07.002 http://www.journalofclinicalvirology.com/article/S1386-6532(13)00277-1/abstract
2. Fiebig EW, Wright DJ, Rawal BD, et al. Dynamics of HIV viremia and antibodyseroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS. 2003;17(13):1871-1879.
*Average shelf life received by customer (product has a 15 month shelf life from date of manufacture)
**From date of manufacture
A Leader In Rapid Point-of-care Diagnostics.
©2024 Abbott. All rights reserved. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Abbott takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage.
Your use of this website and the information contained herein is subject to our Website Terms and Conditions and Privacy Policy. Photos displayed are for illustrative purposes only. Any person depicted in such photographs is a model. GDPR Statement
Not all products are available in all regions. Check with your local representative for availability in specific markets. For in vitro diagnostic use only. For i-STAT test cartridge information and intended use, refer to individual product pages or the cartridge information (CTI/IFU) in the i-STAT Support area.
Abbott - A Leader in Rapid Point-of-Care Diagnostics.
